期刊文献+

2002-2005年宁波市常住居民病毒性肝炎死亡分析 被引量:1

Analysis on death cases of viral hepatitis among regular residents in Ningbo,from 2002 to 2005
暂未订购
导出
摘要 目的了解2002-2005年宁波市常住居民病毒性肝炎死亡的流行病学特征。方法利用宁波市居民病伤死亡报表和死亡医学证明书数据库,用描述流行病学方法进行分析。结果2002-2005年宁波市病毒性肝炎死亡率为10.21/10万,其死亡数占传染病死亡数的71.79%。病毒性肝炎的死亡型别以乙型病毒性肝炎(乙肝)居多,所占比例为64.81%。89.44%的病毒性肝炎死者死于慢性肝炎,急性肝炎死亡仅占2.94%。4年间宁波市肝癌死亡病例中伴随病毒性肝炎者占15.58%,其中65.93%是乙肝。结论慢性乙型病毒性肝炎应是防治的重点。 Objective The present study was conducted to analyze the epidemiological characteristics of death cases of viral hepatitis among regular residents of Ningbo from 2002 to 2005. Methods Descriptive epidemiological analyses were conducted based on the diseases and injury deaths reporting tables and the database of death certificates for residents in Ningbo. Results The mortality rate of viral hepatitis in Ningbo from 2002 to 2005 was 10.21 /lakh, and the death cases accounted for 71.79% of all deaths of infectious diseases. Hepatitis B was the main type of viral hepatitis in death cases with the proportion of 64.81%. Chronic viral hepatitis death cases accounted for 89.44%, while acute viral hepatitis death cases for only 2.94%. The proportion of viral hepatitis as the contributory cause of liver cancer in death cases was 15.58% for the last four years in Ningbo, hepatitis B accounting for 65.93%. Conclusion The prevention and control of chronic viral hepatitis B should be highly focused on.
出处 《疾病监测》 CAS 2007年第8期529-530,共2页 Disease Surveillance
关键词 病毒性肝炎 死亡 流行病学 viral hepatitis death epidemiology
  • 相关文献

参考文献6

二级参考文献10

  • 1WHO. State of the World's Vaccines and Immunization[R]. 2002.
  • 2WHO Department of Immunization, Vaccines and Biologicals. Core information for the development of immunization policy 2002 update[M]. Geneva,World Health Organisation. 2003.
  • 3WHO. Global progress towards universal childhood hepatitis B vaccination, 2003[J]. Wkly Epidemiol Rec, 2003,78 (42): 366 - 370.
  • 4Global Alliance for Vaccines and Immunization.GAVI Milestones,2003.Available at http://www.vaccinealliance.org/home/General Information/About alliance/Background/milestones. Php
  • 5Lok AS. Hepatitis B infection: pathogenesis and management. J Hepatol, 2000, 32 : 89-97.
  • 6Boyer N, Marcellin P. Pathogenesis, diagnosis and management of hepatitis C. J Hepatol, 2000, 32:98-112.
  • 7Cui SN, Wang MM. Primary study on anti-HBV efficacy of bifenda te in treatment of chronic hepatitis B. Reported on Scientific similar of DDB be tween Egypt and China doctors. Beijing,2001, 8.
  • 8Montasser MF. A clinical and laboratory study of DDB in treatme nt of chronic hepatitis C.(2) comparative studies. Ain Shams Medical Journal. 20 00, 51:209-223.
  • 9郭传勇,钱珍华.中药防治肝纤维化研究现状[J].上海铁道大学学报,1998,19(11):77-79. 被引量:4
  • 10许国章.宁波市三十年来病毒性肝炎流行病学分析[J].浙江预防医学,1990,2(4):9-11. 被引量:1

共引文献131

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部